Genor Biopharma Holdings Limited (06998)
Genor Biopharma Holdings Limited, a biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally. The company's principal drug candidates include GB242, an infliximab (Remicade) biosimilar for rheumatoid arthritis, ankylosing spondylitis, psoriasis, adult ulcerative colitis, and Crohn's disease; GB491 (lerociclib), an oral CDK4/6 inhibitor for breast cancer;
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
